Some visit links earn us a commission.
Quick verdict
Medvi is the better pick for most patients on overall scoring. Medvi runs a compounded-semaglutide and tirzepatide model at flat monthly pricing, with no lock-in and rapid intake. Comparable to Henry Meds and Mochi on price; less established clinical depth than Form Health or Knownwell. Best fit for cash-pay patients who want predictable monthly cost with minimal friction.
That said, GoodRx for Weight Loss wins on specific dimensions. GoodRx turned its drug-pricing reach into a real telehealth program, with branded GLP-1 priced separately and published upfront. The subscription is $119/mo at the standard rate (it opened at a $39/mo introductory rate through January 2026). Medication runs separately: the injection is $199/mo for the first two fills then $349/mo ongoing, and the oral Wegovy pill is from $149/mo. Ongoing all-in about $468/mo. Branded only, billed in two parts, with no member outcome record yet.
Side-by-side
| Medvi | GoodRx for Weight Loss | |
|---|---|---|
| Starts from | $299/mo (incl. medication) | $468/mo (incl. medication) |
| Monthly cost gap | Medvi is $239/mo cheaper than GoodRx for Weight Loss | |
| Lock-in | Month-to-month | Month-to-month |
| Time to prescription | 2 days | 2 days |
| Consultation type | Asynchronous | Telemedicine |
| Affiliate network | Direct | Direct |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Medvi | GoodRx for Weight Loss | |
|---|---|---|
| Pricing transparency | 8/10 | 6/10 |
| Cancellation terms | 8/10 | 8/10 |
| Onboarding experience | 7/10 | 7/10 |
| Medication options | 7/10 | 7/10 |
| Member reviews | 9/10 | 8.8/10 |
When to choose Medvi
Best for flat compounded with no lock-in
Cash-pay patients who want flat predictable compounded GLP-1 pricing with no lock-in and same-week onboarding. Strong fit if you've taken GLP-1 before and want a simple ongoing prescription channel.
Medvi wins on pricing transparency, member reviews and runs $239/mo cheaper than GoodRx for Weight Loss at the entry tier ($179 vs $418). Over a year that's $2,868 you keep. The caveat: Insurance-pathway shoppers, patients with multiple comorbidities needing clinical depth or anyone wanting branded Wegovy or Zepbound through standard PA. Note also: Compounded GLP-1 carries 503A regulatory exposure; see compounded callout
When to choose GoodRx for Weight Loss
Best for published two-part pricing
Buyers who want transparent, published cash pricing on both care and branded medication, from a familiar drug-pricing brand.
GoodRx for Weight Loss wins on tied dimensions on the dimensional scoring. The caveat: Anyone wanting a compounded option, an all-in single price, or a long member-review track record.
If cost is your main filter
Medvi is the cheaper monthly: $179 all-in vs $418 for GoodRx for Weight Loss. That's $239 a month or $2,868a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $717 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Medvi (month-to-month) and GoodRx for Weight Loss (month-to-month) sit at the same cancellation tier. Read both cancellation policies directly before signing; the on-page summary covers the headline but not the deletion-of-account or refund-window edge cases.
FAQ
Is Medvi cheaper than GoodRx for Weight Loss?
Can I switch from Medvi to GoodRx for Weight Loss mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
